Abstract
A new synthetic route was elaborated at our laboratory providing a convenient access to 5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-ones (diazaoxindoles), a compound family of biological relevance. Treatment of the easily available ethyl 2-(4-chloropyrimidin-5-yl)acetate derivatives with ammonia afforded the corresponding 2-(4-aminopyrimidin-5-yl)acetamides, which were finally cyclized to the target compounds.
Graphical abstract
Similar content being viewed by others
References
Shepherd TA, Dally RD, Joseph S (2010) Akt and p70 S6 kinase inhibitors. US Patent Appl. US 2010120801, 13 May 2010
Shepherd TA, Dally RD, Joseph S (2010) Akt and p70 S6 kinase inhibitors. PCT Int. Pat. Appl. WO 2010056563, 20 May 2010
Shepherd TA, Dally RD, Joseph S (2010) Chem Abstr 152:568154
Mitchell IS, Spencer KL, Stengel P, Han Y, Kallan NC, Munson M, Vigers GPA, Blake J, Piscopio A, Josey J, Miller S, Xiao D, Xu R, Rao C, Wang B, Bernacki AL (2005) Akt protein kinase inhibitors. PCT Int. Patent Appl. WO 2005051304, 9 June 2005
Mitchell IS, Spencer KL, Stengel P, Han Y, Kallan NC, Munson M, Vigers GPA, Blake J, Piscopio A, Josey J, Miller S, Xiao D, Xu R, Rao C, Wang B, Bernacki AL (2005) Chem Abstr 143:40007
Follmann M, Stasch J-P, Redlich G, Lang D, Vakalopoulos A, Wunder F, Tersteegen A (2014) Trifluoromethyl-substituted fused pyrimidines and their use. US Patent Appl. US 2014249168, 4 Sep 2014
Follmann M, Stasch J-P, Redlich G, Lang D, Vakalopoulos A, Wunder F, Tersteegen A (2014) Chem Abstr 161:404656
Follmann M, Stasch J-P, Redlich G, Ackerstaff J, Griebenow N, Knorr A, Wunder F, Li VM-J, Kroh W, Baerfacker L (2012) Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases. PCT Int. Patent Appl. WO 2012004258, 12 Jan 2012
Follmann M, Stasch J-P, Redlich G, Ackerstaff J, Griebenow N, Knorr A, Wunder F, Li VM-J, Kroh W, Baerfacker L (2012) Chem Abstr 156:175315
Raghavan S, Stelmach JE, Smith CJ, Li H, Whitehead A, Waddell ST, Chen Y-H, Miao S, Ornoski OA, Garfunkle J, Liao X, Chang J, Han X, Guo J, Groeper JA, Brockunier LL, Rosauer K, Parmee ER (2011) Soluble guanylate cyclase activators. PCT Int. Patent Appl. WO 2011149921, 1 Dec 2011
Raghavan S, Stelmach JE, Smith CJ, Li H, Whitehead A, Waddell ST, Chen Y-H, Miao S, Ornoski OA, Garfunkle J, Liao X, Chang J, Han X, Guo J, Groeper JA, Brockunier LL, Rosauer K, Parmee ER (2011) Chem Abstr 155:11159
Joule JA, Mills K (2000) Heterocyclic chemistry, 4th edn. Blackwell Science Ltd, Oxford, p 218
Sun CL, Li X, Zhu Y (2009) Bioactive compounds for treatment of cancer and neurodegenerative diseases. PCT Int. Patent Appl. WO 2009139834, 19 Nov 2009
Sun CL, Li X, Zhu Y (2009) Chem Abstr 151:571128
Choi H-S, Wang Zh, Richmond W, He X, Yang K, Jiang T, Sim T, Karanewsky D, Gu X, Zhou V, Liu Y, Ohmori O, Caldwell J, Graya N, Hea Y (2006) Bioorg Med Chem Lett 16:2173
Neelamkavil SF, Boyle CD, Harris JM, Stamford AW, Hao J, Neustadt BR, Chackalamannil S, Xia Y, Greenlee WJ (2010) Bicyclic heterocycle derivatives and their use as GPCR modulators. PCT Int. Patent Appl. WO 2010009207, 21 Jan 2010
Neelamkavil SF, Boyle CD, Harris JM, Stamford AW, Hao J, Neustadt BR, Chackalamannil S, Xia Y, Greenlee WJ (2010) Chem Abstr 152:192137
Leftheris K, Barrish J, Hynes J, Wrobleski ST (2002) Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors. PCT Int. Patent Appl. WO 2002040486, 23 May 2002
Leftheris K, Barrish J, Hynes J, Wrobleski ST (2002) Chem Abstr 136:386144, also published as: EP 1363910
Johnson TB, Peck HT, Ambler JA (1911) J Am Chem Soc 33:758
Vaid RK, Spitler JT, Boini S, May SA, Hoying RC (2012) Synthesis 44:2396
Hennequin LFA, Ple P, Lohmann JM, Thomas AP (1999) Oxindolylquinazoline derivatives as angiogenesis inhibitors. PCT Int. Patent Appl. WO 1999010349, 3 Mar 1999
Hennequin LFA, Ple P, Lohmann JM, Thomas AP (1999) Chem Abstr 130:209715
Hunt JT, Bhide RS, Borzilleri RM, Qian L (2000) Pyrrolotriazine inhibitors of kinases. PCT Int. Patent Appl. WO 2000071129, 30 Nov 2000
Hunt JT, Bhide RS, Borzilleri RM, Qian L (2000) Chem Abstr 134:17506
Biggs J, Sykes P (1959) J Chem Soc 1849
Andersag H, Westphal K (1937) Chem Ber 70:2035
Cereced LR, Pickel FD (1937) J Am Chem Soc 59:1714
Cheung M, Harris PA, Lackey KE (2001) Tetrahedron Lett 42:999
Massaroli GG, Signorelli G (1966) Boll Chim Pharm 105:400
Zymalkowski F, Reimann F (1966) Arch Pharm 299:362
Holmes IP, Bergman Y, Lunniss GE, Nikac M, Choi N, Hemley CF, Walker SR, Foitzik RCh, Ganame D, Lessene R (2012) FAK inhibitors. PCT Int. Patent Appl. WO 2012110773, 23 Aug 2012
Holmes IP, Bergman Y, Lunniss GE, Nikac M, Choi N, Hemley CF, Walker SR, Foitzik RCh, Ganame D, Lessene R (2012) Chem Abstr 157:382910
Gravin AI (1943) Zhurnal Prikladnoi Khimii. Russian Federation, Sankt-Petersburg, p 105
Gravin AI (1944) Chem Abstr 38:8327
Andersag H, Westphal K (1945) Pyrimidine derivatives and process of preparing the same. US Patent 2,377,395, 5 June 1945
Andersag H, Westphal K (1946) Chem Abstr 40:570
Verma SD, Dey AN (1963) J Indian Chem Soc 40:283
Verma SD, Dey AN (1963) Chem Abstr 59:41697
Hermecz I, Kereszturi G, Vasvari-Debreczy L (1992) Advances in heterocyclic chemistry. Academic Press Inc, San Diego, p 141
Peters E, Minnemeyer HJ, Spears AW, Tickelmann H (1960) J Org Chem 25:2137
Partyka RA (1965) N,N′-Bis(pyrimidine-5-acetyl)ethylene diamines. US Pat. US 3,225,047, 21 Dec 1965
Partyka RA (1966) Chem Abstr 64:35926
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kókai, E., Nagy, J., Tóth, T. et al. Convenient synthesis of 2-substituted 5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-ones. Monatsh Chem 147, 767–773 (2016). https://doi.org/10.1007/s00706-015-1634-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-015-1634-1